somewhere down the road, somebody is earning more money
August 7, 2017 6:23 PM Subscribe
Consumers have grown accustomed to being told by insurers — and middlemen known as pharmacy benefit managers — that they must give up their brand-name drugs in favor of cheaper generics. But some are finding the opposite is true, as pharmaceutical companies squeeze the last profits from products that are facing cheaper generic competition. Out of public view, corporations are cutting deals that give consumers little choice but to buy brand-name drugs — and sometimes pay more at the pharmacy counter than they would for generics. - Take the Generic, Patients Are Told. Until They Are Not.
This thread has been archived and is closed to new comments